Artificial Pancreas Can Prevent Dangerously Low Blood Sugar in People with Type 1 Diabetes

Image

Artificial Pancreas Can Prevent Dangerously Low Blood Sugar in People with Type 1 Diabetes

A new artificial pancreas system can prevent hypoglycemia episodes of dangerously low blood sugar during and after heavy exercise in people with type 1 diabetes, according to a small study published in The Journal of Clinical Endocrinology & Metabolism.

The researchers tested their new artificial pancreas system on 10 adults with type 1 diabetes during an in-hospital clinical trial, measuring their blood sugar during and three hours after exercise. They found that the artificial pancreas system performed well and was safe during and after heavy exercise in people with type 1 diabetes in comparison with standard therapy.

Full text: https://endocrinenews.endocrine.org/artificial-pancreas-can-prevent-dangerously-low-blood-sugar-in-people-with-type-1-diabetes/

Endocrinology and Metabolism: Open Access is a peer reviewed journal which focuses on the publication of current research and developments on the endocrine glands and its secretions with their coordination with metabolism and reproduction. Endocrinology and Metabolism: Open Access aims to function as the global face of endocrinology research. Subject areas: Endocrine glands and hormones, Hormone metabolism, Structure and physiochemical properties, Paediatric Endocrinology, Endocrine pharmacology, Molecular endocrinology, Gastrointestinal and Neuroendocrinology, Comparative Endocrinology, Cardiovascular endocrinology, Reproductive endocrinology, Hormonal receptors Signalling mechanisms, Hormone regulated gene expression, Intracellular steroid and lipid metabolism, Bone and mineral metabolism. The journal accepts manuscripts in the form of original research article, review article, short communication, case report, letter-to-the-Editor and Editorials for publication in an open access platform. All the articles published in the journal can be accessed online without any subscription charges and will receive the benefit of extensive worldwide visibility.

Submit your manuscript at : https://www.imedpub.com/submissions/endocrinology-metabolism-open-access.html or Send as an attachment to: endometabol@emedscholar.com

Media Contact
Eliza Grace
Associate Managing Editor
Endocrinology and Metabolism: Open Access
E-Mail: endometabol@emedscholar.com